Welcome to CDC Stacks | Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions - 41838 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions
Filetype[PDF - 342.47 KB]


Details:
  • Pubmed ID:
    21760650
  • Pubmed Central ID:
    PMC3134280
  • Funding:
    DA015612-08/DA/NIDA NIH HHS/United States
    R01 DA015612/DA/NIDA NIH HHS/United States
    R18 PS000830/PS/NCHHSTP CDC HHS/United States
    R21 CA122317/CA/NCI NIH HHS/United States
  • Document Type:
  • Collection(s):
  • Description:
    In an era of limited healthcare budgets, mathematical models can be useful tools to identify cost-effective programs and to support policymakers in informed decision making. This paper reports results of our work carried out over several years with the Asian Liver Center at Stanford University, a nonprofit outreach and advocacy organization that is an international leader in the fight against hepatitis B and liver cancer. Hepatitis B is a vaccine-preventable viral disease that, if untreated, can lead to death from cirrhosis and liver cancer. Infection with hepatitis B is a major public health problem, particularly in Asian populations. We used new combinations of decision analysis and Markov models to analyze the cost-effectiveness of several interventions to combat hepatitis B in the United States and China. The results of our OR-based analyses have helped change United States public health policy on hepatitis B screening for millions of people and have helped encourage policymakers in China to enact legislation to provide free catch-up vaccination for hundreds of millions of children. These policies are an important step in eliminating health disparities, reducing discrimination, and ensuring that millions of people who need it can now receive hepatitis B vaccination or lifesaving treatment.